Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Dreyer

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Journal of Translational Research|April 12, 2021
Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancerWeiwei Gong, Caixia Zhu, Yueyang Liu, et al.
American Journal of Cancer Research|July 10, 2020
High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patientsXiaocong Geng, Lamiya Babayeva, Axel Walch, et al.
Oncoimmunology|May 4, 2018
Prognosis of ovarian cancer is associated with effector memory CD8<sup>+</sup> T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cellsSonja Lieber, Silke Reinartz, Hartmann Raifer, et al.
Molecular Medicine (Cambridge, Mass.)|February 8, 2020
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patientsWeiwei Gong, Yueyang Liu, Sarah Preis, et al.
Cancers|January 11, 2022
tRNA<sup>GlyGCC</sup>-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and ProgressionKonstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
American Journal of Cancer Research|July 10, 2023
Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancerYueyang Liu, Weiwei Gong, Konstantina Panoutsopoulou, et al.
Molecular Oncology|February 19, 2026
Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high-grade serous ovarian cancerSophia Bielesch, Isabel Vogel, Sina Nokodian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paperOliver Goldhardt, Robert Freiberger, Tobias Dreyer, et al.
Cancers|December 1, 2020
KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate CancerBrian W-C Tse, Thomas Kryza, Mei-Chun Yeh, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Translational Research|April 12, 2021
Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancerWeiwei Gong, Caixia Zhu, Yueyang Liu, et al.
American Journal of Cancer Research|July 10, 2020
High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patientsXiaocong Geng, Lamiya Babayeva, Axel Walch, et al.
Oncoimmunology|May 4, 2018
Prognosis of ovarian cancer is associated with effector memory CD8<sup>+</sup> T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cellsSonja Lieber, Silke Reinartz, Hartmann Raifer, et al.
Molecular Medicine (Cambridge, Mass.)|February 8, 2020
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patientsWeiwei Gong, Yueyang Liu, Sarah Preis, et al.
Cancers|January 11, 2022
tRNA<sup>GlyGCC</sup>-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and ProgressionKonstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
American Journal of Cancer Research|July 10, 2023
Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancerYueyang Liu, Weiwei Gong, Konstantina Panoutsopoulou, et al.
Molecular Oncology|February 19, 2026
Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high-grade serous ovarian cancerSophia Bielesch, Isabel Vogel, Sina Nokodian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paperOliver Goldhardt, Robert Freiberger, Tobias Dreyer, et al.
Cancers|December 1, 2020
KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate CancerBrian W-C Tse, Thomas Kryza, Mei-Chun Yeh, et al.
Pageof 3